David: a case report in facioscapulohumeral muscular dystrophy

Change in Shoulder Elevation and Gait Following a Myofascial Intervention in a Man with Genetically Confirmed Facioscapulohumeral Muscular Dystrophy and Post-Concussion Syndrome: A Case Report

G. Blair Lamb, MD and Patrick Wagner, NMF Science LLC

First documented October 2025. Revised October 2026 to follow the CARE case report guidelines.

This case report is self-published by NMF Science LLC and has not been peer reviewed. It describes one patient. FSHD is a genetic condition, and nothing in this report suggests the condition itself was treated or changed. Most outcomes were reported by the patient and assessed by the treating clinician, not measured independently, and the report does not show that the intervention caused the changes described. The limitations are set out in full in the Discussion.

ABSTRACT

Introduction. Facioscapulohumeral muscular dystrophy (FSHD) is a genetic muscular dystrophy with slowly progressive weakness, most often of the face, shoulder girdle and upper arms, and later the lower legs. There is no approved disease-modifying treatment, and lost strength is not expected to return. People with FSHD can also have coexisting musculoskeletal problems, including after injury, that add to their functional limitation and are not always assessed separately from the dystrophy. This report describes a man with genetically confirmed FSHD and post-concussion syndrome whose shoulder elevation and gait changed after a procedure directed at myofascial findings in the spine.

Patient and findings. A [50]-year-old man with FSHD confirmed by genetic testing presented with bilateral scapular winging, lateral arm elevation limited to about [80] degrees on each side, recurrent foot drop on both sides, lower-limb heaviness and fatigue, and the symptoms of post-concussion syndrome following a head injury sustained in sport, including constant headache, light sensitivity, eye pain, jaw pain and bilateral tinnitus. Examination found widespread tenderness and restriction of the paraspinal muscles and fascia at several cervical and thoracic levels.

Intervention and outcomes. He received a myofascial procedure directed at the identified cervical and thoracic sites. Within about 30 minutes of the first session, lateral arm elevation was observed to increase from about [80] degrees to full range on both sides. At follow-up he reported no further episodes of foot drop, easier walking, less frequent headache, quieter tinnitus, and a return to recreational golf about once a week. Full bilateral arm elevation was observed at subsequent visits. He has continued to receive sessions at intervals of about six months, and the changes were reported as maintained at three years.

Conclusion. A change in shoulder elevation within minutes cannot reflect any change in the dystrophic muscle, and nothing in this case suggests the FSHD was affected. The observation raises a narrower question: whether a coexisting, treatable musculoskeletal problem of the spine was contributing to this patient’s shoulder restriction and gait difficulty alongside the dystrophy. Outcomes other than arm elevation were patient-reported and assessed by the treating clinician, and no standardized measure was used. The case suggests that assessing for such problems in people with FSHD and a history of injury is worth studying with objective measures and independent assessment.

INTRODUCTION

Facioscapulohumeral muscular dystrophy (FSHD) is one of the more common adult muscular dystrophies, with a population-based prevalence of about 12 per 100,000 [1]. It is caused by inappropriate expression of the DUX4 gene in skeletal muscle, most often through contraction of the D4Z4 repeat region on chromosome 4q35 [2]. Weakness is slowly progressive and often asymmetric, typically involving the face, the muscles that stabilize the scapula, and the upper arms, with later involvement of the ankle dorsiflexors causing foot drop. Scapular winging limits shoulder abduction and overhead reach. There is no approved disease-modifying treatment, and management is supportive: exercise, orthoses, and in selected patients surgical scapular fixation [3]. Lost strength is not expected to return.

Disability in FSHD is not determined only by the dystrophic process. Chronic pain is reported by about 80% of people with FSHD, and the American Academy of Neurology guideline recommends that treating physicians routinely ask about it [3,4]. The marked variability in severity between affected family members, and the asymmetry often seen within one person, show that factors beyond the genetic lesion shape how the condition presents. Coexisting musculoskeletal problems, including those that follow injury, can add to functional limitation and are not always assessed separately from the dystrophy.

This report follows the CARE guidelines for case reports [5,6]. It describes one man with genetically confirmed FSHD and post-concussion syndrome in whom a structured examination of the spine and surrounding soft tissue identified widespread myofascial restriction, and in whom shoulder elevation and gait changed after a procedure directed at those findings. It is reported as a single observation to prompt study, not as evidence of effect, and it makes no claim about the dystrophy itself.

CASE PRESENTATION

Patient Information and Clinical History

A 50-year-old man, a teacher and former athlete, was first assessed in July 2022. FSHD had been confirmed by genetic testing showing contraction of the D4Z4 repeat region on chromosome 4q35 on a permissive haplotype. His father and brothers were also affected, with variable severity within the family. He remained under the care of his own physicians for the dystrophy throughout the period described here.

Seven years earlier he had sustained a head injury playing basketball, after which post-concussion syndrome had been diagnosed. Since then he had had constant headache with light sensitivity, constant bilateral tinnitus, and constant neck and back pain. In the years after his FSHD diagnosis he had developed progressive bilateral shoulder weakness, lower-limb heaviness and weakness, and gastrointestinal symptoms. His weakness was roughly symmetric.

Presenting Symptoms

At the first visit he reported:

  • Bilateral shoulder weakness with limited arm elevation
  • Constant headache with light sensitivity
  • Constant bilateral tinnitus
  • Constant neck and back pain
  • Lower-limb heaviness and weakness, with difficulty climbing stairs
  • Inability to walk any distance
  • Inability to play golf because of upper and lower limb weakness
  • Gastrointestinal symptoms

Clinical Findings at Baseline Examination

Baseline examination was recorded in July 2022. Where a finding was reported by the patient rather than examined, this is stated.

Neurological: Facial weakness consistent with FSHD. Pronounced bilateral scapular winging. Active lateral elevation of the arms was limited to approximately 80 degrees on each side; below that point shoulder abduction strength was estimated at 3/5 bilaterally, and above it he could generate no movement. Lower-limb strength was estimated at 4/5 in the quadriceps and other groups tested. Sensation was intact to gross testing and reflexes were normal. Light sensitivity was evident during the examination. Headache, tinnitus and neck and back pain were reported.

Musculoskeletal: Cervical and thoracic range of motion was reduced. Palpation of the cervical and thoracic spine found areas of guarding, tenderness and restriction in the paraspinal muscles and fascia. No imaging was obtained to characterize these findings.

Functional: Unable to walk any distance or to take part in recreational activity requiring the arms and legs.

The clinical impression was post-traumatic myofascial pain of the cervical and thoracic spine, with a cervicogenic contribution to headache, coexisting with established FSHD and post-concussion syndrome. The FSHD diagnosis was not re-evaluated.

CLINICAL EVALUATION AND NEUROMYOFASCIAL AUDIT

Diagnostic Assessment

The FSHD diagnosis had been established by genetic testing before referral and was not re-evaluated. Prior imaging, electrodiagnostic and laboratory results were reviewed; no new investigations were ordered. The purpose of the assessment was to identify musculoskeletal and myofascial contributors to his current functional limitation that might be modifiable, separate from the dystrophy.

The assessment consisted of a detailed history, review of the prior results, and a structured palpatory and functional examination of the spine and limbs. Tenderness, taut bands, guarding, restriction and reproduction of the patient’s symptoms on palpation were recorded for each spinal region, together with range of motion, strength grading and gait. The findings are those reported under Clinical Findings above.

The findings were interpreted as widespread post-traumatic myofascial restriction of the cervical and thoracic spine, bilateral and roughly symmetric, in a distribution consistent with the head and neck injury seven years earlier and with the symmetry of his symptoms. The working hypothesis was that these findings were contributing to, or amplifying, his shoulder restriction, gait difficulty and head and neck symptoms alongside the FSHD, and that treating them might reduce that contribution. This was a clinical interpretation. No diagnostic test, such as a diagnostic block, was performed to confirm it, and the examination cannot separate the mechanical findings from the effects of the dystrophy. Nothing in the assessment bears on the dystrophy itself.

TREATMENT AND OUTCOMES

Therapeutic Intervention

In July 2022 the patient received a transcutaneous myofascial procedure directed at the identified sites in the cervical and thoracic paraspinal region. The session lasted about 30 minutes. No change was made to his other care at the time, and no adverse events were recorded.

He has since received further sessions at intervals of about six months for recurrence of musculoskeletal symptoms, particularly after returning to sport.

Follow-up and Outcomes

Outcomes were assessed by the treating clinician and by the patient’s report. No standardized FSHD, strength or disability measure was used, and no instrumented range of motion or gait measurement was taken. The record documents the first session and the position at three years; interim visits were not documented in a form that can be reported here. At each time point, what the patient reported is listed separately from what was found on examination.

Same day as the first session (July 2022)

On examination, within about 30 minutes of the procedure:

  • Active lateral elevation of the arms had increased from approximately 80 degrees to full range on both sides, and he could hold the arms in the elevated position
  • Gait was observed to be steadier [DR. LAMB: state what was observed, for example stride, foot clearance, or ability to walk a set distance]
  • [DR. LAMB: if shoulder and lower-limb strength were regraded after the procedure, state the grades here against the baseline 3/5 and 4/5. If they were not regraded, delete this line.]

The patient reported, at the same time:

  • Clearer vision and less light sensitivity
  • Less headache
  • Quieter tinnitus
  • Legs felt stronger and lighter

Reassessment about 40 minutes after the procedure found the same examination findings.

Three years (2025)

Reported:

  • Plays golf about once a week, which he had been unable to do before
  • Walks longer distances with less fatigue
  • Sleeps better
  • Thinks more clearly
  • Headache and tinnitus are much less constant than before
  • Daily activities are easier

On examination: full active lateral elevation of both arms. [DR. LAMB: state the strength grade recorded at this visit, if any.] Facial weakness and scapular winging consistent with FSHD remained present.

He attended all planned sessions, no adverse events were recorded, and he remained under the care of his own physicians for the dystrophy throughout.

DISCUSSION

What Was Observed

A man with genetically confirmed FSHD and a seven-year history of post-concussion syndrome had widespread, roughly symmetric myofascial restriction of the cervical and thoracic spine on examination. After a procedure directed at those findings, active lateral elevation of both arms increased from about 80 degrees to full range within about 30 minutes, and he reported changes in headache, light sensitivity, tinnitus and the feeling in his legs at the same time. Three years later he reported that he walks further, plays golf weekly and has fewer symptoms, and full arm elevation was again observed. Facial weakness and scapular winging remained.

Comparison with FSHD Natural History

FSHD is slowly progressive, and lost strength does not return [3]. A change in arm elevation within 30 minutes cannot reflect any change in dystrophic muscle, and nothing in this case suggests the dystrophy was affected: the facial weakness and scapular winging that define the condition were unchanged. The question the case raises is narrower. In FSHD the deltoid is often relatively spared, and arm elevation is limited mainly by failure of the scapula to stay fixed against the chest wall; this is why surgical scapular fixation can increase elevation without changing any muscle [3]. Anything that changes how the scapula sits and moves could therefore change elevation without changing strength. The case asks whether a coexisting, treatable musculoskeletal problem of the spine was contributing to this patient’s shoulder restriction and gait difficulty alongside the dystrophy.

Possible Explanations

Several explanations need to be considered. They are not mutually exclusive.

  • Local effects of the procedure. Any change within 30 minutes has to be considered first in terms of what the procedure does immediately. Mechanical change in soft tissue and a reduction in pain can plausibly alter range of motion within minutes.
  • Pain-mediated inhibition and guarding. Pain and injury change how muscles are recruited and increase stiffness around the painful region [7]. In a patient with seven years of neck and upper back pain, reduced pain and guarding in the paraspinal and periscapular muscles could improve scapular positioning and therefore arm elevation, and could reduce the sense of heaviness in the legs, without any change in the strength of dystrophic muscle. This is the most likely explanation for the examined change and is itself worth studying.
  • Expectation and contextual effects. The patient was treated by a clinician who expected improvement, in a setting designed around it, and outcomes were assessed by the same clinician. Placebo and contextual effects on pain, effort and subjective symptoms can be large and can persist.
  • Measurement variability and effort. Range of elevation was estimated by eye, not measured with a goniometer, and the amount of elevation a person with scapular winging achieves varies with effort, trunk position and compensation strategy.
  • Concurrent care and time. He received further sessions at six-month intervals, returned to sport, and had three years of ordinary life between the two documented time points. The contribution of each cannot be separated, and the durability of the first session on its own cannot be judged.

The reported changes in headache, light sensitivity and tinnitus relate to the post-concussion syndrome rather than to FSHD. They rest entirely on the patient’s report and are not explained by this case.

The Hypothesis This Case Raises

Disability in FSHD is shaped by more than the genetic lesion: pain is reported by most people with the condition [4], severity varies widely within families, and musculoskeletal problems that follow injury can add to functional limitation. The working hypothesis behind this report is that, in some people with FSHD and a history of injury, a coexisting post-traumatic myofascial problem of the spine contributes to limitation that is then attributed to the dystrophy, and that treating it may reduce that contribution. This is a hypothesis about a second, treatable problem alongside FSHD. It makes no claim about the cause or course of the dystrophy, and this case cannot test it. Whether similar findings occur in affected members of the same family is a question for a documented case series, with each person separately assessed and consented.

Limitations

The limitations are substantial. This is one patient. The temporal association between the procedure and the changes does not establish that one caused the other. Baseline and follow-up assessments were made by the treating clinician, with no blinded or independent assessment. Range of motion was estimated, not measured, and no standardized FSHD, strength, pain or disability measure was used. Only the first session and the three-year position are documented; the interval between them is not. The palpatory findings are clinical impressions without imaging correlation. The intervention is described here only in general terms. Both authors have a professional and financial interest in the approach, and the report is self-published and has not been peer reviewed. Nothing in this case can be generalized to other people with FSHD, whose presentation, injury history and response would differ.

What Would Strengthen a Future Report

Future cases should record measured range of motion with a goniometer, graded or dynamometer strength, a timed walk, a pain scale and a disability measure before and after intervention; obtain records or a statement from the patient’s neuromuscular physician; use an assessor who did not deliver the treatment; document the procedure in detail; and set follow-up points in advance. A prospective case series with these features would be the appropriate next step.

CONCLUSION

Conclusion

In one man with genetically confirmed FSHD and post-concussion syndrome, arm elevation and reported function changed after a procedure directed at coexisting myofascial findings in the spine, in a way that cannot reflect any change in the dystrophy and did not change its defining features. The observation does not show that the procedure caused the change, and the most likely explanation for the examined change is a reduction in pain and guarding around the shoulder girdle rather than any change in muscle. It suggests that coexisting musculoskeletal problems, particularly after injury, may be worth assessing separately in people with FSHD. Whether such problems are common in FSHD, whether treating them changes function, and in whom, are questions for a prospective case series with measured outcomes, independent assessment, a documented procedure and pre-set follow-up points.

DECLARATIONS

Authors

G. Blair Lamb, MD. Physician, Ontario, Canada. Treating clinician for the case described. Developer of the assessment and treatment approach described in this report.

Patrick Wagner. Co-founder, NMF Science LLC. Prepared the manuscript from the clinical record.

Author contributions: GBL assessed and treated the patient and documented the clinical findings. PW drafted the report. Both authors reviewed and approved the final version.

Correspondence: Patrick Wagner, NMF Science LLC, patrick@nmfscience.com

Declarations

Patient consent: The patient gave written informed consent for publication of this anonymized case report.

Conflicts of interest: Dr. G. Blair Lamb developed the assessment and treatment approach described in this report and provides it in his practice. Patrick Wagner is co-founder of NMF Science LLC, which publishes educational material about the approach. Both authors therefore have a professional and financial interest in it.

Funding: None.

Data availability: The clinical record is held at the treating practice in accordance with applicable privacy law and professional standards.

Reporting guideline: This report follows the CARE guidelines for case reports [5,6].

Publication status: Self-published by NMF Science LLC. Not peer reviewed.

References

  1. Deenen JC, Arnts H, van der Maarel SM, et al. Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology. 2014;83(12):1056-1059. doi:10.1212/WNL.0000000000000797
  2. Lemmers RJ, van der Vliet PJ, Klooster R, et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science. 2010;329(5999):1650-1653. doi:10.1126/science.1189044
  3. Tawil R, Kissel JT, Heatwole C, et al. Evidence-based guideline summary: evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy. Neurology. 2015;85(4):357-364. doi:10.1212/WNL.0000000000001783
  4. van der Kooi EL, Kalkman JS, Lindeman E, et al. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. J Neurol. 2007;254(7):931-940. doi:10.1007/s00415-006-0432-4
  5. Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Rep. 2013;2013:bcr2013201554. doi:10.1136/bcr-2013-201554
  6. Riley DS, Barber MS, Kienle GS, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218-235. doi:10.1016/j.jclinepi.2017.04.026
  7. Hodges PW, Tucker K. Moving differently in pain: a new theory to explain the adaptation to pain. Pain. 2011;152(3 Suppl):S90-S98. doi:10.1016/j.pain.2010.10.020

This case report is educational. It describes one patient and is not medical advice. It does not describe a treatment anyone should seek. People with FSHD should remain under the care of their neuromuscular physician and care team.

AUTHOR INFORMATION

Authors

G. Blair Lamb, MD. Physician, Ontario, Canada. Treating clinician for the case described. Developer of the assessment and treatment approach described in this report.

Patrick Wagner. Co-founder, NMF Science LLC. Prepared the manuscript from the clinical record.

Author contributions: GBL assessed and treated the patient and documented the clinical findings. PW drafted the report. Both authors reviewed and approved the final version.

Correspondence: Patrick Wagner, NMF Science LLC, patrick@nmfscience.com

Learn About TNPC

Clinical Resources

About NMF Science